Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
100.62
+0.24 (0.24%)
Dec 31, 2025, 10:16 AM EST - Market open
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $7.81 billion as of December 31, 2025. Its market cap has increased by 26.67% in one year.
Market Cap
7.81B
Enterprise Value
6.85B
1-Year Change
26.67%
Ranking
Category
Stock Price
$100.62
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $7.81B, an increase of 881.68%. That is a compound annual growth rate of 67.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 7.80B | 40.15% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |